Literature DB >> 32776828

Testosterone supplementation upregulates androgen receptor expression and translational capacity during severe energy deficit.

Emily E Howard1,2,3, Lee M Margolis1, Claire E Berryman1,2,4, Harris R Lieberman1, J Philip Karl1, Andrew J Young1,2, Monty A Montano5,6,7, William J Evans8,9, Nancy R Rodriguez3, Neil M Johannsen10, Kishore M Gadde10, Melissa N Harris10, Jennifer C Rood10, Stefan M Pasiakos1.   

Abstract

Testosterone supplementation during energy deficit promotes whole body lean mass accretion, but the mechanisms underlying that effect remain unclear. To elucidate those mechanisms, skeletal muscle molecular adaptations were assessed from muscle biopsies collected before, 1 h, and 6 h after exercise and a mixed meal (40 g protein, 1 h postexercise) following 14 days of weight maintenance (WM) and 28 days of an exercise- and diet-induced 55% energy deficit (ED) in 50 physically active nonobese men treated with 200 mg testosterone enanthate/wk (TEST) or placebo (PLA) during the ED. Participants (n = 10/group) exhibiting substantial increases in leg lean mass and total testosterone (TEST) were compared with those exhibiting decreases in both of these measures (PLA). Resting androgen receptor (AR) protein content was higher and fibroblast growth factor-inducible 14 (Fn14), IL-6 receptor (IL-6R), and muscle ring-finger protein-1 gene expression was lower in TEST vs. PLA during ED relative to WM (P < 0.05). Changes in inflammatory, myogenic, and proteolytic gene expression did not differ between groups after exercise and recovery feeding. Mechanistic target of rapamycin signaling (i.e., translational efficiency) was also similar between groups at rest and after exercise and the mixed meal. Muscle total RNA content (i.e., translational capacity) increased more during ED in TEST than PLA (P < 0.05). These findings indicate that attenuated proteolysis at rest, possibly downstream of AR, Fn14, and IL-6R signaling, and increased translational capacity, not efficiency, may drive lean mass accretion with testosterone administration during energy deficit.

Entities:  

Keywords:  androgen receptor; inflammation; muscle mass; myonuclear accretion; negative energy balance; translational capacity

Mesh:

Substances:

Year:  2020        PMID: 32776828      PMCID: PMC7750513          DOI: 10.1152/ajpendo.00157.2020

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  61 in total

1.  Translational studies in older men using testosterone to treat sarcopenia.

Authors:  Randall J Urban; E L Dillon; S Choudhary; Y Zhao; A M Horstman; R G Tilton; M Sheffield-Moore
Journal:  Trans Am Clin Climatol Assoc       Date:  2014

2.  Post-absorptive muscle protein turnover affects resistance training hypertrophy.

Authors:  Paul T Reidy; Michael S Borack; Melissa M Markofski; Jared M Dickinson; Christopher S Fry; Rachel R Deer; Elena Volpi; Blake B Rasmussen
Journal:  Eur J Appl Physiol       Date:  2017-03-09       Impact factor: 3.078

3.  Severe energy deficit at high altitude inhibits skeletal muscle mTORC1-mediated anabolic signaling without increased ubiquitin proteasome activity.

Authors:  Lee M Margolis; John W Carbone; Claire E Berryman; Christopher T Carrigan; Nancy E Murphy; Arny A Ferrando; Andrew J Young; Stefan M Pasiakos
Journal:  FASEB J       Date:  2018-06-07       Impact factor: 5.191

4.  Supplementing an energy adequate, higher protein diet with protein does not enhance fat-free mass restoration after short-term severe negative energy balance.

Authors:  C E Berryman; J J Sepowitz; H L McClung; H R Lieberman; E K Farina; J P McClung; A A Ferrando; S M Pasiakos
Journal:  J Appl Physiol (1985)       Date:  2017-04-06

5.  TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine.

Authors:  Charu Dogra; Harish Changotra; Nia Wedhas; Xuezhong Qin; Jon E Wergedal; Ashok Kumar
Journal:  FASEB J       Date:  2007-02-21       Impact factor: 5.191

6.  Effects of graded doses of testosterone on erythropoiesis in healthy young and older men.

Authors:  Andrea D Coviello; Beth Kaplan; Kishore M Lakshman; Tai Chen; Atam B Singh; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2007-12-26       Impact factor: 5.958

7.  Validity of midday total testosterone levels in older men with erectile dysfunction.

Authors:  R Charles Welliver; Herbert J Wiser; Robert E Brannigan; Kendall Feia; Manoj Monga; Tobias S Köhler
Journal:  J Urol       Date:  2014-02-08       Impact factor: 7.450

8.  Resident muscle stem cells are not required for testosterone-induced skeletal muscle hypertrophy.

Authors:  Davis A Englund; Bailey D Peck; Kevin A Murach; Ally C Neal; Hannah A Caldwell; John J McCarthy; Charlotte A Peterson; Esther E Dupont-Versteegden
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-17       Impact factor: 4.249

9.  Myofibrillar muscle protein synthesis rates subsequent to a meal in response to increasing doses of whey protein at rest and after resistance exercise.

Authors:  Oliver C Witard; Sarah R Jackman; Leigh Breen; Kenneth Smith; Anna Selby; Kevin D Tipton
Journal:  Am J Clin Nutr       Date:  2013-11-20       Impact factor: 7.045

10.  Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men.

Authors:  Nima Gharahdaghi; Supreeth Rudrappa; Matthew S Brook; Iskandar Idris; Hannah Crossland; Claire Hamrock; Muhammad Hariz Abdul Aziz; Fawzi Kadi; Janelle Tarum; Paul L Greenhaff; Dumitru Constantin-Teodosiu; Jessica Cegielski; Bethan E Phillips; Daniel J Wilkinson; Nathaniel J Szewczyk; Kenneth Smith; Philip J Atherton
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-09-30       Impact factor: 12.910

View more
  6 in total

1.  Testosterone undecanoate administration prevents declines in fat-free mass but not physical performance during simulated multi-stressor military operations.

Authors:  Alyssa N Varanoske; Melissa N Harris; Callie Hebert; Emily E Howard; Neil M Johannsen; Steven B Heymsfield; Frank L Greenway; Lee M Margolis; Harris R Lieberman; Robbie A Beyl; David D Church; Arny A Ferrando; Stefan M Pasiakos; Jennifer C Rood
Journal:  J Appl Physiol (1985)       Date:  2022-07-07

2.  A systemic study on the vulnerability and fatality of prostate cancer patients towards COVID-19 through analysis of the TMPRSS2, CXCL10 and their co-expressed genes.

Authors:  Md Thosif Raza; Shagufta Mizan
Journal:  Genomics Inform       Date:  2022-09-30

3.  Molecular Regulators of Muscle Mass and Mitochondrial Remodeling Are Not Influenced by Testosterone Administration in Young Women.

Authors:  Oscar Horwath; Marcus Moberg; Angelica Lindén Hirschberg; Björn Ekblom; William Apró
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

4.  Exposure to sevoflurane results in changes of transcription factor occupancy in sperm and inheritance of autism†.

Authors:  Hsiao-Lin V Wang; Samantha Forestier; Victor G Corces
Journal:  Biol Reprod       Date:  2021-09-14       Impact factor: 4.285

Review 5.  Lean mass sparing in resistance-trained athletes during caloric restriction: the role of resistance training volume.

Authors:  C Roth; B J Schoenfeld; M Behringer
Journal:  Eur J Appl Physiol       Date:  2022-02-11       Impact factor: 3.346

6.  Effects of testosterone undecanoate on performance during multi-stressor military operations: A trial protocol for the Optimizing Performance for Soldiers II study.

Authors:  Alyssa N Varanoske; Melissa N Harris; Callie Hebert; Emily E Howard; Neil M Johannsen; Steven B Heymsfield; Frank L Greenway; Lee M Margolis; Harris R Lieberman; David D Church; Arny A Ferrando; Jennifer C Rood; Stefan M Pasiakos
Journal:  Contemp Clin Trials Commun       Date:  2021-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.